GoodRx Holdings Q2 Adj EPS $0.07 Beats $0.06 Estimate, Sales $189.70M Beat $186.82M Estimate
Portfolio Pulse from Benzinga Newsdesk
GoodRx Holdings reported Q2 adjusted earnings of $0.07 per share, beating the analyst consensus estimate of $0.06 by 16.67%. The company's quarterly sales were $189.70 million, surpassing the analyst consensus estimate of $186.82 million by 1.54%. However, this represents a 1.09% decrease compared to the same period last year.
August 09, 2023 | 10:03 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
GoodRx Holdings reported better-than-expected Q2 earnings and sales, but experienced a slight decrease in sales compared to the same period last year.
GoodRx's better-than-expected earnings and sales for Q2 are likely to positively impact its stock price in the short term. However, the slight decrease in sales compared to the same period last year could temper this positive impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100